Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer
Table 1
General characteristics of patients.
Variable
Median (range or absolute frequency)
Age (year)
54 (27–80)
Gender (female)
42 (40.8%)
Tumor location (pyloric antrum)
50 (48.5%)
HER-2 (positive)
28 (27.2%)
TNM stage I-II/III/IV
20 (19.4%)/25 (24.3%)/58 (56.3%)
Metastasis (yes)
58 (56.3%)
RDW (%)
13.4 (11.5–32.7)
WBC (g/L)
5.69 (3.03–12.81)
MO (g/L)
0.42 (0.11–1.46)
NLR
2.54 (1.00–32.28)
CA125 (U/mL)
26.6 (4.0–4853.6)
CA199 (U/mL)
11.9 (2.0–1200.0)
CEA (μg/L)
2.4 (0.5–12854.0)
RDW + NLR 0/1/2
38 (36.9%)/37 (35.9%)/28 (27.2%)
Overall survival
8.9 (0.9–51.7)
Progression-free survival
6.1 (0.9–51.7)
RDW: red cell distribution width; NE: neutrophil; MO: monocyte; PDW: platelet distribution width; NLR: neutrophil-to-lymphocyte ratio; RDW + NLR: combination of red blood cell distribution width and neutrophil-to-lymphocyte ratio.
